Paper · 11262395
Bcl-rambo, a novel Bcl-2 homologue that induces apoptosis via its unique C-terminal extension.
Kataoka T and 6 others. J Biol Chem, 2001. Cited by 119 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Bcl-rambo, a novel Bcl-2 homologue that induces apoptosis via its unique C-terminal extension. Papers, record 11262395. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11262395
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Bcl-rambo, a novel Bcl-2 homologue that induces apoptosis via its unique C-terminal extension.
- PubMed
Topics25
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Apoptosis | Major topic |
| Proto-Oncogene Proteins c-bcl-2 | Major topic |
| Amino Acid Motifs | |
| Amino Acid Sequence | |
| Blotting, Northern | |
| Blotting, Western | |
| Cell Death | |
| Cell Line | |
| Cloning, Molecular | |
| Cytochrome c Group | |
| DNA, Complementary | |
| Gene Library | |
| HeLa Cells | |
| Humans | |
| Microscopy, Confocal | |
| Microscopy, Fluorescence | |
| Models, Genetic | |
| Molecular Sequence Data | |
| Plasmids | |
| Precipitin Tests | |
| Protein Binding | |
| Protein Structure, Tertiary | |
| Sequence Homology, Amino Acid | |
| Tissue Distribution | |
| Transfection |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by66
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 119 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,896,204 | Variant-divergent death: Omicron intensifies bystander T-cell apoptosis via GDF15-BCL2L13. | Cell Death Discov | 2026 | https://conductscience.org/library/papers/41896204 | PubMed |
| 41,486,294 | Mitophagy in the pathogenesis and management of disease. | Cell Res | 2026 | https://conductscience.org/library/papers/41486294 | PubMed |
| 41,341,510 | Receptor-mediated mitophagy: a new target of neurodegenerative diseases. | Front Neurol | 2025 | https://conductscience.org/library/papers/41341510 | PubMed |
| 40,140,445 | Multi-omics integration identifies molecular markers and biological pathways for carcass and meat quality traits in Nellore cattle. | Sci Rep | 2025 | https://conductscience.org/library/papers/40140445 | PubMed |
| 39,857,806 | Bcl-2 and Bcl-xL in Diabetes: Contributions to Endocrine Pancreas Viability and Function. | Biomedicines | 2025 | https://conductscience.org/library/papers/39857806 | PubMed |
| 39,580,803 | AMPK regulates Bcl2-L-13-mediated mitophagy induction for cardioprotection. | Cell Rep | 2024 | https://conductscience.org/library/papers/39580803 | PubMed |
| 39,322,603 | New Mitochondria-Targeted Fisetin Derivative Compromises Mitophagy and Limits Survival of Drug-Induced Senescent Breast Cancer Cells. | J Med Chem | 2024 | https://conductscience.org/library/papers/39322603 | PubMed |
| 39,215,014 | AI-powered omics-based drug pair discovery for pyroptosis therapy targeting triple-negative breast cancer. | Nat Commun | 2024 | https://conductscience.org/library/papers/39215014 | PubMed |
| 39,175,772 | BCL2L13 at endoplasmic reticulum-mitochondria contact sites regulates calcium homeostasis to maintain skeletal muscle function. | iScience | 2024 | https://conductscience.org/library/papers/39175772 | PubMed |
| 38,392,190 | Molecular Characterization and Expression Changes of the bcl2l13 Gene in Response to Hypoxia in Megalobrama amblycephala. | Curr Issues Mol Biol | 2024 | https://conductscience.org/library/papers/38392190 | PubMed |
1 to 10 of 66
See all 66 cited byGenes10
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BCL2L13 | 23,786 | Swiss-Prot's references | https://conductscience.org/library/genes/23786 | NCBI Gene |
| BAK1 | 578 | PubTator's text mining | https://conductscience.org/library/genes/578 | NCBI Gene |
| BAX | 581 | PubTator's text mining | https://conductscience.org/library/genes/581 | NCBI Gene |
| BCL2 | 596 | PubTator's text mining | https://conductscience.org/library/genes/596 | NCBI Gene |
| BCL2L1 | 598 | PubTator's text mining | https://conductscience.org/library/genes/598 | NCBI Gene |
| BCL2L11 | 10,018 | PubTator's text mining | https://conductscience.org/library/genes/10018 | NCBI Gene |
| BCL2L2 | 599 | PubTator's text mining | https://conductscience.org/library/genes/599 | NCBI Gene |
| BID | 637 | PubTator's text mining | https://conductscience.org/library/genes/637 | NCBI Gene |
| BIK | 638 | PubTator's text mining | https://conductscience.org/library/genes/638 | NCBI Gene |
| MCL1 | 4,170 | PubTator's text mining | https://conductscience.org/library/genes/4170 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data1
The data bank entries PubMed's record names. Trial numbers are under Trials.
| Data bank | Accession |
|---|---|
| GENBANK | AF325209 |
Source GENBANK
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/11262395
GET https://conductscience.org/api/papers/v1/11262395/cited_by?page=2